Company Overview and News

 
Investors turn to voting power to take stand on women on boards

6h thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
BHP Trims Iron Ore Guidance—How Iron Ore Prices Could Respond

8h marketrealist
On April 18, BHP Billiton (BHP) released its operational review of the nine months ended March 2018. Iron ore (PICK) volumes are key to BHP Billiton’s revenues and earnings, as iron ore is the largest commodity produced by the company.
Upvote Downvote

 
Why Commodity Stocks Surged on April 18—All You Need to Know

9h marketrealist
April 18, 2018, belonged to commodity stocks (COMT), some of which saw their highest one-day gains in months. Among the iron ore and diversified companies, Glencore (GLNCY) surged 7.7%, and Anglo American (AAUKY) saw price gains of 6.2%. BHP Billiton (BHP), Rio Tinto (RIO), Vale SA (VALE), and Cleveland-Cliffs (CLF) rose 3.3%, 4.0%, 4.2%, and 4.4%, respectively.
Upvote Downvote

 
Key Factors that Are Helping Iron Ore Prices

9h marketrealist
Prices for iron ore and other commodities dependent on China’s growth were expected to get a lift after President Trump’s conciliatory tweets following a speech by China’s leader, Xi Jinping. However, that boost didn’t materialize. Commodity prices got a boost from the latest data out of China—especially related to its property market.
Upvote Downvote

 
Iron Ore Prices Surge on China’s Cut in Reserve Ratio Requirement

9h marketrealist
While the broader surge in commodities helped iron ore prices, China’s (FXI)(MCHI) surprise cut in its reserve ratio requirement (or RRR) for some Chinese lenders from the People’s Bank of China led to price gains in iron ore. The cash that most commercial and foreign banks must hold as reserves is expected to be cut by 100 basis points. This change is expected to take effect on April 25, 2018.
Upvote Downvote

 
Big Investors Push Harder for More Women Directors - Bloomberg

10h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
BHP Billiton (BHP) Lowers Iron-Ore Production View for FY18

11h zacks
BHP Billiton Limited (BHP - Free Report) recently released third-quarter fiscal 2018 (ended March 2018) operational results. Aggregate iron-ore output came in at 58 million tons (Mt) during the reported quarter, up 8% year over year. However, the company lowered its iron-ore production guidance for fiscal 2018 (ending June 2018) from 239-243 Mt to 236-238 Mt range. The company stated that the outlook has been revised primarily due to the ongoing car dumper reliability problems.
Upvote Downvote

 
RPT-U.S. customers scramble to replace Rusal metal after sanctions

13h reuters
NEW YORK, April 19 (Reuters) - U.S. customers of Rusal are scrambling to figure out how to replace supply from the Russian company after U.S. sanctions on the world’s second-largest aluminum producer caused prices to spike to a seven-year high, the companies and metals analysts said.
Upvote Downvote

 
Australian miners surge as base metals, oil and iron ore 'melt up'

17h abc.net.au
Australian miners and energy producers have been carried along in the slipstream of surging commodity prices across a range of markets.
Upvote Downvote

 
ASX lifts on strong commodities

18h smh.com.au
The Australian market recorded its fifth session in a row without loss on Thursday, as strong commodity prices helped lift mining stocks.
Upvote Downvote

 
ASX lifts on strong commodities

18h theage.com.au
The Australian market recorded its fifth session in a row without loss on Thursday, as strong commodity prices helped lift mining stocks.
Upvote Downvote

 
Alcoa's (AA) CEO Roy Harvey on Q1 2018 Results - Earnings Call Transcript

22h seekingalpha
Good afternoon, and welcome to the Alcoa Corporation First Quarter 2018 Earnings Presentation and Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
Upvote Downvote

 
U.S. customers scramble to replace Rusal metal after sanctions

23h reuters
NEW YORK (Reuters) - U.S. customers of Rusal are scrambling to figure out how to replace supply from the Russian company after U.S. sanctions on the world’s second-largest aluminum producer caused prices to spike to a seven-year high, the companies and metals analysts said.
Upvote Downvote

 
Energy, metals push Aust market higher

2018-04-19 businessnews.com.au
The Australian share market has opened higher after stronger commodities prices lifted BHP, Rio Tinto and shares in other miners.
Upvote Downvote

 
Market report: Miners drive FTSE to 10-week high

2018-04-18 telegraph.co.uk
London's mining giants propelled the FTSE 100 to a 10-week high as the fallout from US sanctions gripped metal markets, analysts predicted a huge surge in aluminium prices and Glencore’s long-standing interest in Bunge was being speculated on by chattering traders.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...